Keyphrases
Advanced Therapy Medicinal Products
13%
Allogeneic
8%
Apoptosis
13%
Articular Cartilage
8%
B-cell Lymphoma 2 (Bcl-2)
12%
BHRF1
10%
Bioprocess
16%
Bone Healing
11%
Bone Marrow
20%
Bone Marrow Cells
10%
Bone Marrow Mononuclear Cells
12%
Cardiac Repair
8%
Cartilage
8%
Cartilage Resurfacing
8%
CD105
7%
CD90
7%
Cell Therapy
28%
Cell Viability
8%
Cell-based
35%
Cell-derived
7%
Clinical Application
42%
Clinical Grade
41%
Clinical Translation
10%
Critical Quality Attributes
15%
Europe
10%
Extracellular Vesicles
11%
Focal Defect
13%
Gene Therapy
7%
Good Manufacturing Practice
23%
HLA-DR
16%
Human Mesenchymal Stem Cells (hMSCs)
33%
Immunopotency
8%
International Society
11%
Large Animal Model
8%
Long Bone
10%
Manufacturing Process
7%
Mesenchymal Stroma
14%
Mesenchymal Stromal Cells
68%
Multipotent
9%
Multipotent Mesenchymal Stromal Cells
43%
Osteoarthritis Treatment
8%
Osteochondral
10%
PLGA Scaffold
10%
Production Process
8%
Pseudarthrosis
16%
Regenerative Medicine
16%
Sheep
15%
Umbilical Cord Blood
11%
Wharton's Jelly
20%
WJ-MSCs
10%
Medicine and Dentistry
Adoptive Immunotherapy
5%
Advanced Therapy
12%
Adverse Event
6%
Articular Cartilage
13%
Autograft
5%
Biological Marker
10%
Blood Sampling
5%
Cartilage
5%
Cell Expansion
5%
Cell Therapy
20%
Clinical Trial
13%
Cord Blood
13%
Cytomegalovirus
5%
Engineered Tissue
10%
Ex Vivo
13%
Fracture Healing
6%
Health Care Cost
5%
Human Leukocyte Antigen
10%
Iliac Crest
6%
Immunomodulation
5%
Induced Pluripotent Stem Cell
5%
Injury
13%
Interleukin 17F
5%
Interleukin 33
5%
Knee
10%
Magnetic Resonance Imaging
9%
Medicine
30%
Mesenchymal Stem Cell
100%
Myocardial Infarction
9%
Nonunion
8%
Organoid
5%
Osteoarthritis
7%
Peripheral Blood Mononuclear Cell
5%
Polyglactin
5%
Polyglycolide
5%
Polylactide
5%
Progenitor Cell
5%
Pseudarthrosis
16%
Quality of Life
6%
T Lymphocyte
5%
Tissue Graft
5%
Tissue Regeneration
12%
Wharton Jelly
23%
